With circular funding and "off-book" debts, the $2 trillion AI boom looks less like a revolution and more like a catastrophic bubble waiting to burst.
In light of litifilimab recently receiving FDA Breakthrough Therapy Designation for CLE, we spoke with experts to discuss diagnostic and treatment gaps in disease management.
Top insights from the latest market news from Monday, March 16, from The Motley Fool analysts on Team Rule Breakers and Team ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results